RONALD S.W. LEW, District Judge.
Currently before the Court are the following Motions: (1) Cross-Claimant Bill Biltagi's Motion for Summary Judgment [99]; (2) Cross-Claimant Yousef Rabadi and Intesar Alturk's Motion for Summary Judgment [100] (collectively, "Cross-Claimants' Motions"); (3) and Cross-Defendant Brian C. Lysaght and Lysaght Law Group's Motion for Summary Judgment or in the Alternative Summary Adjudication ("Cross-Defendants' Motion") [118-1]. Having reviewed all papers submitted pertaining to this Motion, the Court
Cross-Claimants Bill Biltagi, Yousef Rabadi, and Intesar Alturk (collectively, "Cross-Claimants")
Cross-Claimant Bill Biltagi was listed on beneficiary transfer papers as the Insured's "business associate," and holds a 9% interest in the Policy. Lewis Decl. Ex. B. He was the owner of the Policy upon the Insured's death and remains the owner to this day. Tauler Decl. Ex. A, at 489. Yousef Rabadi was identified as the Insured's son, and later her nephew, on Policy documentation.
Cross-Defendants Brian C. Lysaght and Lysaght Law Group (collectively, "Cross-Defendants") are a law firm that entered into a contingency fee agreement with its clients, Josef Rabadi, Reem Rabadi, and Sandra Rabadi (collectively, "State Court Rabadis") regarding representation in
Abraham Khader ("Khader"), was a licensed life settlement insurance broker who prepared the Insured's life insurance applications.
Nabil Yousef Rabadi is the Insured's brother, who was a joint owner of the Policy at one point. Tauler Decl. Ex. A, at 395, 489. Reem Al-Rabadi is Yousef Rabadi's mother and Nabil Rabadi's wife, listed as a contingent beneficiary on the Policy.
On April 8, 2011, the Insured applied with Transamerica for a 10-Year Level Term life insurance policy totaling $4,000,000.
On September 21, 2011, Yousef Rabadi—initially listed as the Insured's "son," then later her "nephew"—was designated the primary beneficiary.
For the first six months, the Policy premium payments were $11,000 per quarter.
Khader initially refused to file a questionnaire that asked questions to ferret out whether the Policy was a Stranger Oriented Life Insurance ("STOLI") Policy.
On April 9, 2013, the Insured transferred 100% of the ownership in the Policy to Nabil Rabadi, her brother and Yousef Rabadi's father.
When Policy benefits became due, the Policy provided life insurance coverage totaling $5,500,000.
On April 11, 2011, the State Court Rabadis (Josef, Reem, and Sandra) filed
Cross-Defendants entered into a contingency fee agreement with the State Court Rabadis.
Another section defined the "Attorney's Lien:"
On March 4, 2014, Lotta—Khader's attorney in the Orange County Action—and Khader allegedly met with the State Court Rabadis unbeknownst to Cross-Defendants. Am. Decl. of Natasha Riggs ("Riggs Am. Decl.") ¶ 9, ECF No. 124. At that meeting, Khader apparently induced the State Court Rabadis into dismissing the State Court Action against him and Intesar Alturk in return for future compensation from other life insurance policies.
On April 15, 2014, Cross-Defendants filed a Notice of Attorney's Lien in the State Court Action. Decl. of Vivian I. Orlando ("Orlando Decl.") Ex. 1, ECF No. 84-2. The Notice of Lien provided:
The State Court Rabadis dismissed their claims against Khader and Intesar Alturk in the State Court Action on May 7, 2014, and the case was ultimately dismissed for failure to prosecute on July 1, 2016. Riggs Decl. Ex. 11, ECF No. 121-10. Per Cross-Defendants, the State Court Rabadis invested in Khader's improper policies, filed a lawsuit against him, then rejoined the enterprise upon dismissing the State Court Action against Khader and Intesar Alturk. Lysaght Supp. Decl. ¶ 17.
The Insured died on May 18, 2015. Lewis Decl. Ex. C. Bill Biltagi filed his claim for benefits to the Policy on June 2, 2015, claim number 505200394159, as did the other Cross-Claimants. Lewis Decl. Ex. D; Decl. of Bill Biltagi ("Biltagi Decl.") ¶ 5, ECF No. 99-1. On June 29, 2015, Cross-Defendants advised Transamerica that their Lien applied to up to 30% of the Policy proceeds, triggering the instant Interpleader Action in federal court. Orlando Decl. Ex. 2.
On September 18, 2015, Transamerica paid the undisputed 70% of the Policy proceeds to Cross-Claimants' client trust account. Compl. ¶ 20, ECF No. 1. Because Transamerica was unable to determine which parties were owed the remaining 30% of the Policy death benefits ("Policy proceeds" or "interpled funds"), totaling $1,653,354.67, it filed a Complaint in Interpleader on September 29, 2015 [1]. The interpled funds are on deposit with the Court as of October 7, 2015 [8].
On January 11, 2016, Cross-Defendants filed their Answer to the Complaint-In-Interpleader, asserting various affirmative defenses [15]. On January 13, 2016, Cross-Claimants filed their Answer to the Complaint-In-Interpleader [20] and Cross-Claim against Cross-Defendants, (1) for declaratory judgment that Cross-Defendants do not have an enforceable Lien against either Cross-Claimants or the Policy, and seeking a determination of their rights to the Policy proceeds. Cross-Cl. ¶ 9, ECF No. 22.
Cross-Claimants filed a Motion to Strike Cross-Defendants' Affirmative Defenses in its Answer to the Complaint-in-Interpleader on February 1, 2016 [28], which the Court granted in part and denied in part [51]. On June 8, 2016, Cross-Defendants filed an Answer to the Cross-Complaint, raising affirmative defenses for unclean hands, illegal STOLI policy, and conspiracy [66] (emphasis added). Cross-Claimants did not file a Motion to Strike this answer.
On December 21, 2016, the Court granted Transamerica's Motion to Dismiss, discharging it of all liability regarding the Policy and allowing the case to proceed between Cross-Claimants and Cross-Defendants [97].
On February 28, 2017, Cross-Claimants separately filed Motions for Summary Judgment as to the Complaint-In-Interpleader and Cross-Claim for Declaratory Relief [99, 100]. The Court received Cross-Defendants' Oppositions to the Motions for Summary Judgment on March 7, 2017 and March 8, 2017 [106, 109] and Cross-Claimants' joint Reply on March 13, 2017 [112, 138]. Cross-Defendants filed their own Motion for Summary Judgment as to their affirmative defenses on March 14, 2017 [118-1]. Cross-Claimants' separate Oppositions followed on March 21, 2017 [129, 133], and Cross-Defendants filed their Reply on March 28, 2017 [141].
1. The Insured was insured under Transamerica Life Insurance Policy number 60160747. Cross-Cl. Bill Biltagi's Stmt. of Uncontroverted Facts ("Biltagi's SUF") ¶ 1, ECF No. 99-5; Cross-Cls.' Yousef Rabadi & Intesar Alturk's Stmt. of Uncontroverted Facts ("Rabadi's SUF") ¶ 1, ECF No. 100-1;
2. The Rabadi State Court Action was filed on April 7, 2011. Cross-Defs.' Stmt of Uncontroverted Facts ("Cross-Defs.' SUF") ¶ 24, ECF No. 120; Biltagi's RJN Ex. 3, at 1667.
3. On June 2, 2015, Bill Biltagi filed his claim for benefits under the Policy, Claim number 505200394159. Biltagi's SUF ¶ 8; Lewis Decl. Ex. D, at 57.
4. On May 5, 2013, the State Court Rabadis signed a Retainer agreement with Cross-Defendants. Biltagi's SUF ¶ 11; Rabadi's SUF ¶ 4; Cross-Defs.' SUF ¶ 65; Boniadi Decl. Ex. 1.
5. On October 1, 2013, change in beneficiary forms submitted to Transamerica changed the Policy owners and beneficiaries as follows: Nabil Yousef Rabadi (50%); Bill Biltagi (50%). Cross-Defs.' SUF ¶ 66; Tauler Decl. Ex. A, at 411-414.
6. Cross-Defendants filed a Notice of Attorney's Lien in Los Angeles Superior Court Case number BC459192,
7. Around May 2014, Cross-Defendants served Transamerica's counsel with a copy of its Notice of Attorney's Lien. Biltagi's SUF ¶ 17; Rabadi's SUF ¶ 6; Orlando Decl. ¶ 2, Ex. 1.
8. Transamerica, the corporation, received a copy of the Notice of Attorney's Lien on or around May 13, 2014. Biltagi's SUF ¶ 18; Rabadi's SUF ¶ 6; Lewis Decl. ¶ 8, Ex. F.
9. The Insured died on May 18, 2015, and Cross-Claimants, the Beneficiaries, made claims to the full Policy proceeds. Biltagi's SUF ¶¶ 19-20; Rabadi's SUF ¶¶ 7-8; Lewis Decl. Exs. C-D.
10. The Insured and Yousef Rabadi have never been Cross-Defendants' clients. Biltagi's SUF ¶ 26;
Federal Rule of Civil Procedure 56 states that a "court shall grant summary judgment" when the movant "shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law." Fed. R. Civ. P. 56(a). A fact is "material" for purposes of summary judgment if it might affect the outcome of the suit, and a "genuine issue" exists if the evidence is such that a reasonable fact-finder could return a verdict for the non-moving party.
Under Rule 56, the party moving for summary judgment has the initial burden to show "no genuine dispute as to any material fact." Fed. R. Civ. P. 56(a);
A court "may judicially notice a fact that is not subject to reasonable dispute because it: (1) is generally known . . .; or (2) can be accurately and readily determined from sources whose accuracy cannot reasonably be questioned." Fed. R. Evid. 201(b). A court "must" take judicial notice "if a party requests it and the court is supplied with the necessary information." Fed. R. Evid. 201(c)(2).
Bill Biltagi asks the Court to take judicial notice of the following ("Biltagi's RJN"): (1) Lewis and Orlando Declarations attached to Transamerica's Motion to Dismiss [84-1, 84-2]; (2) Caption pages of the Complaint and First Amended Complaint and court docket portion of the State Court Action,
The Court may take judicial notice of previous filings in the same litigation between the same parties, like the Lewis and Orlando Declarations.
Cross-Claimants Yousef Rabadi and Intesar Alturk seek judicial notice of the following ("Rabadi's RJN"): (1) Transamerica's Complaint-In-Interpleader filed on September 29, 2015 [1]; (2) the Court's Order Directing Deposit of Interpleader Funds on October 7, 2015 [8]; (3) Cross-Defendants' Answer to the Complaint-in-Interpleader, filed on January 11, 2016 [15]; (4) Cross-Claimants' Answer to the Complaint-in-Interpleader, filed on January 13, 2016 [20]; (5) Lewis Declaration attached to Transamerica's Motion to Dismiss, filed on October 18, 2016 [84-1]. Rabadi's Req. for Jud. Ntc. ("Rabadi's RJN") ¶¶ 1-5, Exs. 1-5, ECF No. 100-2.
Because "it is well established that a court can take judicial notice of its own files and records under Rule 201,"
Cross-Defendants ask the Court to take judicial notice ("Cross-Defendants' First RJN") of the minute order in
The Court can consider
Cross-Defendants also seek judicial notice of the following: 1) Cross-Claimants' Rule 26 Initial Disclosures from this case; (2) the California Department of Insurance Amended Accusation against Khader and Alturk, dated November 17, 2016; and (3) the Verdict and Special Findings in
"Discovery items such as requests for discovery and responses to requests for discovery are not proper subjects for judicial notice because they are not `self-authenticating' and thus cannot be verified."
A court may "take judicial notice of the existence of another court's opinion or of the filing of pleadings in related proceedings; the Court may not, however, accept as true the facts found or alleged in such documents."
The Court can consider
Accordingly, the Court
Bill Biltagi objects to the Roth Declaration [126] in its entirety. Steven Roth was a disclosed, non-testifying expert in
Bill Biltagi objects to the Riggs Declaration in its entirety and the attached exhibits on the grounds of irrelevance, inadequate evidentiary foundation, hearsay, and violation of Federal Rule of Civil Procedure 56(c)(4), among other things. Biltagi's Objs. ¶¶ 10-24, ECF No. 130. The Riggs Declaration [121] includes exhibits like the Third Amended Complaint in the Orange County Action, Cross-Defendants' requests for production and interrogatories in this action, a Status Conference Statement in the State Court Action, depositions in the Orange County Action, and State Bar searches for Lotta.
The Court
Cross-Claimants object to the Third Riggs Declaration [143] in its entirety on the following grounds: irrelevant, lacks foundation, conclusory, and that it violates Federal Rule of Civil Procedure 56(c)(4). Biltagi's Objs. to Third Riggs Decl. ¶ 1, ECF No. 146. They also object to Exhibits 17-23 attached to the Third Riggs Declaration.
The Court
Cross-Defendants object to specific paragraphs of the Biltagi Declaration on the following grounds: lack of foundation, improper legal conclusion and improper lay opinion, lack of foundation, lack of personal knowledge, inadmissible hearsay.
Because many of Defendant's objections are boilerplate and "devoid of any specific argument or analysis as to why any particular exhibit or assertion in a declaration should be excluded,"
The Court
The Court now turns to the merits of Cross-Defendants' Motion. The case boils down to this issue: whether a law firm may assert its attorney's lien—from a contingency fee agreement with clients in a state court action—against life insurance policy proceeds to which its clients are not beneficiaries, whether through the lien's express terms or through affirmative defenses allegedly linking the state-court clients to the policy beneficiaries.
Cross-Defendants move for summary judgment as to the affirmative defenses in their Answer to the Cross-Complaint [66]: illegality, unclean hands, and conspiracy. Cross-Defs.' Mot. 2:22-24. The Court cannot grant summary judgment as to these defenses.
Cross-Defendants ask that the Court determine the Policy is illegal for two reasons. First, the Policy violated the California Life Settlement Act ("CLSA") because the April 11, 2013 ownership transfer from the Insured to Nabil Rabadi was made for a price less than the death benefit, but was not conducted by a licensed life settlement broker.
Bill Biltagi counters that the STOLI Policy argument is moot, as (1) Transamerica already paid out the Policy proceeds and the two-year contestability period—to challenge or rescind the Policy—lapsed; (2) a life insurance policy is freely assignable as long as the owner has an insurable interest when the Policy was issued; and (3) Cross-Defendants lack standing to attack the Policy's legality because they are not the insurer, Transamerica. Biltagi's Opp'n 7:21-25-8:19.
The Court first addresses Cross-Claimants' counterarguments. Cross-Claimants' point—that Cross-Defendants cannot challenge the Policy's validity, as the contestability window lapsed—is only facially true. Insurance policies in California are incontestable after they have been in issuance for two years, during the lifetime of the insured. Cal. Ins. Code § 10113.5. Here, the policy was issued in 2011 and the Insured died in 2015. The contestability period apparently lapsed in 2013. But the Court recognizes Cross-Defendants' allegation that Khader disguised STOLI policies through straw buyers and fraudulent applications for at least two years to avoid the contestability window. Cross-Defs.' Ans. ¶ 15;
Cross-Claimants also argue that the Policy was freely assignable due to Victoria Rabadi, the Insured's, insurable interest from the outset. Although an individual with an insurable interest may lawfully "have the policy made payable to whomsoever he or she pleases, regardless of whether the beneficiary designated has an insurable interest," Cal. Ins. Code. § 10110.1(b), the Insured and Cross-Claimants' insurable interest here is suspect.
The next issue is whether there are no genuine disputes of material fact as to whether this was a STOLI policy. A STOLI policy is a life insurance policy made for the benefit of a third-party investor who "at the time of policy origination, has no insurable interest, under the laws of this state, in the life of the insured." Cal. Ins. Code. § 10113.1(w). And "[a]ny device, scheme, or artifice designed to give the appearance of an insurable interest where there is no legitimate insurable interest violates the insurable interest laws."
Per Cross-Defendants, Khader and Cross-Claimants associated in a widespread STOLI scheme. Cross-Defs.' Ans. ¶ 12. Khader recruited the Insured, an older woman of modest means, as a "straw buyer" in his STOLI policy scheme. Cross-Defs.' Mot. 19:5. He misrepresented her net worth in order to issue a high-value life insurance policy.
For support, Cross-Defendants cite a handful of out-of-circuit cases involving garden-variety STOLI policies factually similar to the one at hand.
Cross-Defendants' argument—that there are no genuine disputes regarding the STOLI policy issue—is impeded by this remaining dispute: how the Lien applies to the interpled funds. True, the Court did previously acknowledge that Cross-Defendants' affirmative defenses would "directly impact . . . the proper recipient of the Policy proceeds," and if successful, would "reduce or bar Cross-Claimants' claim to the Policy proceeds." Order re Mot. to Strike 5:8-13, ECF No. 51. But even if the affirmative defenses showed that Cross-Claimants were improper beneficiaries, this would not guarantee that Cross-Defendants have a stake in the interpled funds. To succeed on that assumption, Cross-Defendants must clearly show how the Lien terms apply to the interpled funds, which the Court takes up in
The Court is similarly puzzled as to how the Policy's alleged illegality permits Cross-Defendants' seemingly unrelated Lien from the State Court Action to attach to the interpled funds. Cross-Defendants claim the Policy is illegal, yet in the same breath demand their share of proceeds from this apparently illegal Policy. It would appear that Cross-Defendants raise the illegality affirmative defense to ferret out the improper beneficiaries. Even if Cross-Defendants are an interested party in law or equity who may dispute the Policy's validity, Cross-Defendants provide the Court little guidance as to why their Lien should apply once the Policy's illegality is established.
Cross-Defendants argue that the April 11, 2013 ownership transfer of the Policy-from the Insured to Nabil Rabadi-violated the CLSA, California Insurance Code § 10113.1 et seq, and was therefore void as a matter of law. Cross-Defs.' Reply 10:14-16. As Cross-Defendants state, "transfers of ownership for a price less than the death benefit [are] illegal if not conducted by a licensed Life Settlement broker."
While the CLSA does not have a code section precisely stating that a licensed Life Settlement broker must oversee a transfer for a price less than the death benefit, Cross-Defendants read this illegal transfer into section 10113.2(b)(1), as an act of "broker[ing]" or "solicit[ing]" that only a licensed broker can perform. Cross-Defendants state that Cross-Claimants never produced documentary evidence that the Insured received compensation for the ownership change and Khader, not Nabil Rabadi, was always the insurance agent on the Term Policy, and Increased Policy and Universal Policy. Cross-Defs.' SUF 19:6-9.
Setting aside the stark lack of authority or explanation as to this alleged CLSA violation, Cross-Defendants also do not make it clear how and why Nabil Rabadi—and not Khader, the broker who apparently orchestrated much of the Policy paperwork—initiated the ownership transfer. The ownership change forms appear only to be initiated and signed by Nabil Rabadi and the Insured. But the facts presented are too sparse to confidently say there are no genuine disputes as to whether the Policy violated the CLSA. Even were the Court to find that the transfer required a broker and was thus invalid, Cross-Defendants still have not have linked their Lien to the interpled funds.
Per Cross-Defendants, the undisputed facts establish that Cross-Claimants were involved in Khader's conspiracy to issue fraudulent and illegal STOLI policies, including the Policy at issue.
Section 10113.1(g) of the California Insurance Code defines a "fraudulent life settlement act" as "[p]resenting, causing to be presented, or prepared . . . false material information [regarding] the following. . . [a]n application for the issuance of a life settlement contract or insurance policy . . . payments and changes in ownership or beneficiary made in accordance with the terms of a life settlement contract or insurance policy." Other fraudulent life settlement acts include "entering into stranger-originated life insurance (STOLI)."
Cross-Claimants committed fraudulent life settlement acts, Cross-Defendants argue, by presenting false information about the Insured's net worth on her life insurance application. Cross-Defs.' Mot. 22:10-15. Moreover, Cross-Claimants "knew" that they were conspiring to present materially false information regarding Policy payments and ownership/beneficiary changes through the following facts: (1) Yousef Rabadi wrote that he was the Insured's son and then her nephew; (2) Khader's assistant filled out premium payment checks on Yousef Rabadi's behalf; and (3) Intesar Alturk pretended she was the Insured's "business associate," even though she was Khader's mother.
Under California law, the elements of civil conspiracy are "the formation and operation of the conspiracy and damage resulting to the plaintiff from an act or acts done in furtherance of a common design."
In
But even if there are facts supporting the overall conspiracy, Cross-Defendants run into the same problem as in their "STOLI policy" argument: bridging the gap as to why—if Khader and Cross-Claimants engaged in a conspiracy—Cross-Defendants' Lien applies to the interpled funds and precisely how they have a stake in the purportedly ill-gotten Policy proceeds. From what the Court can glean in Cross-Defendants' moving papers, Khader and Lotta's forced discharge of Cross-Defendants—after an improper ex parte meeting with the State Court Rabadis—"welcomed back" the State Court Rabadis into the Khader conspiracy. Cross-Defs.' Mot. 24:10-15. Apparently, the Lien is connected to the Policy proceeds through the "backdoor effort to avoid [Cross-Defendants'] contingency fee," which in turn facilitated the Khader conspiracy.
But Cross-Defendants present no concrete evidence substantiating this tenuous connection. Cross-Defendants and the State Court Rabadis were never beneficiaries to the Policy, nor are they parties to this interpleader action. Biltagi Decl. ¶¶ 2, 5. Cross-Claimants were never Cross-Defendants' clients in the State Court Action with the Lien. Rabadi Decl. ¶ 9, Ex. 1 (email from Cross-Defendants to Yousef Rabadi advising that they are not his attorneys). Cross-Defendants evince no agreement between Cross-Claimants and the State Court Rabadis allowing the State Court Rabadis to share in the Policy proceeds, let alone any evidence that the State Court Rabadis were ever paid the interpled funds. Biltagi Decl. ¶ 9. Moreover, Cross-Defendants have no evidence that Cross-Claimants and a third-party, like Lotta or Khader, conspired to prevent them from recovering under their Lien.
In sum, Cross-Defendants cannot argue that there are no genuine disputes as to validity of their illegality and conspiracy claims, as—even assuming the Policy is invalid and Cross-Claimants are embroiled in a conspiracy, thus barring or reducing Cross-Claimants' claims to the Policy—a dispute remains whether Cross-Defendants have standing to raise these affirmative defenses as a third-party, whether through their Lien or otherwise. Thus, the Court
The Court now considers Cross-Claimants' Motions for Summary Judgment.
Cross-Claimants argue that Cross-Defendants cannot assert a claim against the interpled funds because Cross-Defendants did not bring an "independent action" against the State Court Rabadis to establish the Lien's value and enforceability from the outset. Rabadi's Mot. 3:17-21; Biltagi's Mot. 3:10-12. Cross-Defendants counter that the interpleader action Transamerica filed constitutes an "independent action" to enforce the Lien. Cross-Defs.' Opp'n 14:1-2. Cross-Defendants' Lien is problematic for two reasons: (1) the interpleader action in this case does not constitute an independent action, and (2) the contingency set forth in the Lien did not take place, thus never triggering the Lien.
An attorney's lien is an equitable right to secure attorneys' fees owed from a judgment or recovery in the lawsuit.
Shortly after they were discharged, Cross-Defendants filed a Notice of Attorney's Lien on April 15, 2014, which provides:
As the California Court of Appeals recently held, the independent action need not be a formal complaint; interpleader may suffice.
In
Cross-Defendants claim that, per
The Lien is also unenforceable because the contingency stated in the contingency fee agreement never came to fruition. "[L]iens created in a contingency fee contract" are not enforceable until the occurrence of the stated contingency."
Even were the Court to assume that Cross-Defendants established the Lien's validity, the fact remains that the Lien is inapplicable to the interpled funds.
Per Cross-Claimants, the Lien does not apply to the interpled funds unless Cross-Defendants can show the State Court Rabadis would receive the Policy proceeds in the State Court Action. Biltagi's Mot. at 15:4-8. Cross-Defendants counter that the lack of a direct relationship between Cross-Claimants and the State Court Rabadis does not necessarily deny it relief.
The Lien terms make it clear that they govern proceeds from the State Court Action. As contemplated in the contingency fee agreement, the Lien applies to "causes of action that are the subject of the representation." Boniadi Decl. Ex. 1, at 8. The Lien would attach to "any recovery obtained, whether by arbitration, award, judgement, settlement or otherwise."
The onus is on Cross-Defendants to connect any recovery in the State Court Action to the interpled funds. Cross-Defendants again vaguely argue about the overarching "Khader enterprise." Khader apparently is the common figure duping the State Court Rabadis and apparently manipulating the current Cross-Claimants into his insurance fraud scheme. Because the State Court Action and this case both encompass Khader's far-flung wrongdoing, Cross-Defendants' logic goes, any wrongful payments from Khader in the State Court Action—whether for cooperating with the case's dismissal or otherwise—are intertwined with the Policy proceeds. But Cross-Defendants still cannot overcome that the Lien's terms only apply to the State Court Rabadis, and none of the Cross-Claimants are mentioned.
The following disputed facts also apparently link the Lien and its applicants, the State Court Rabadis, to the interpled funds: Intesar Alturk is a member of Khader's illegal enterprise; in 2004, Intesar Alturk extended a line of credit to Josef Rabadi, a State Court Rabadi, totaling $650,000; Intesar Alturk paid Reem Rabadi, another State Court Rabadi, "hundreds of thousands of dollars;" Intesar Alturk transferred over $1.6 million to Josef Rabadi in 2007; and Cross-Claimants and the State Court Rabadis are from the same family and share the same address. Cross-Defs.' SUF ¶¶ 6-8.
Cross-Defendants have made little effort to marshal these facts in such a way that would convince the Court that the Lien from the State Court Action applies here. Intesar Alturk, a Cross-Claimant in this case, purportedly paid Josef Rabadi, one of Cross-Defendants former clients, over $1.6 million in 2005 and 2007. Cross-Defs.' SUF ¶ 8. These alleged events occurred well over 6-8 years before Cross-Defendants even signed the contingency fee agreement with the State Court Rabadis in May 2013. And vague references to Cross-Claimants' role in Khader's "enterprise" do nothing to bridge the wide gap between the Lien's terms and the interpled funds here. This is not a problem of the Court's interpretation of the Lien-the Lien is quite explicit about how and to what funds it applies. If Cross-Defendants sought to advocate for a different, plausible interpretation of the Lien, they had a burden to do so in their moving papers. They did not meet this burden.
At bottom, Cross-Defendants try to chip away at Cross-Claimants' rights to the interpled funds by arguing extensively about the illegality and conspiracy affirmative defenses. Cross-Defendants file countless declarations, exhibits, and raise a dizzying array of facts, many of which are repeated allegations from the State Court Action and information gleaned from the Orange County Action. And still, Cross-Defendants never expressly address how the Lien attaches to the interpled funds. Cross-Defendants' argument, in essence, is one of default: if Cross-Claimants are not entitled to the tainted Policy proceeds, then Cross-Defendants, by default, receive them. Biltagi's Opp'n 3:12-18. No matter how correct Cross-Defendants' affirmative defenses might be in isolation, Cross-Defendants still cannot get their Lien's validity and applicability off the ground.
Cross-Defendants have not created genuine disputes as to whether the Lien is valid and applicable. As such, the Court grants Cross-Claimants' Motions for Summary Judgment as to the (1) Complaint-In-Interpleader; and (2) the Cross-Claim seeking a declaratory judgment that the Lien is unenforceable and inapplicable to the interpled funds.
Thus, the Court